Zun Yang, Haijiao Li, Wenrui Zhang, Mingzu Zhang, Jinlin He, Zepeng Yu, . . . Peihong Ni. (2023). CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects. MDPI AG.
Chicago Style (17th ed.) CitationZun Yang, Haijiao Li, Wenrui Zhang, Mingzu Zhang, Jinlin He, Zepeng Yu, Xingwei Sun, and Peihong Ni. CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects. MDPI AG, 2023.
MLA (9th ed.) CitationZun Yang, et al. CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.